Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>Ph+ * > Treatment > Co.: USA. B. Brand Dasatinib**

---

Co.: USA. B. Brand Dasatinib**'s subsections
(*) Adults>
(*) Children>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 01.23
Patent>US Expiration:2020. 04.03
TradeMark
TradeMark Web-Site

Co.: USA. B. Brand Dasatinib**'s products
This section has no products